Sen. Bill Cassidy, chair of the Senate Health Committee, expressed lingering doubts about President Trump’s nominee for the FDA, Dr. Heidi Overton, ahead of the committee’s upcoming vote. During a CBS News interview, host Margaret Brennan asked Cassidy to elaborate on the concerns that remain. Cassidy indicated that questions about Overton’s qualifications and suitability have not yet been fully addressed. The committee’s decision on her nomination is expected later this week.
Sen. Bill Cassidy (R-La.) on Sunday said there are still questions left unanswered about President Trump's pick to lead the Food and Drug Administration (FDA), Dr. Heidi Overton, ahead of the Senate Health Committee's vote on her nomination this week. "Face the Nation" host Margaret Brennan asked Cassidy, the committee's chair, on CBS News if...